{"id":46606,"date":"2022-07-27T00:01:56","date_gmt":"2022-07-26T22:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medx-health-corp-announces-the-launch-of-its-dermatological-screening-services-in-newfoundland-and-labrador\/"},"modified":"2022-07-27T00:01:56","modified_gmt":"2022-07-26T22:01:56","slug":"medx-health-corp-announces-the-launch-of-its-dermatological-screening-services-in-newfoundland-and-labrador","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medx-health-corp-announces-the-launch-of-its-dermatological-screening-services-in-newfoundland-and-labrador\/","title":{"rendered":"MedX Health Corp. Announces the Launch of Its Dermatological Screening Services in Newfoundland and Labrador"},"content":{"rendered":"
\n

\nMedX Health has partnered with <\/i>Central Health, the second largest health authority in Newfoundland and Labrador, to introduce DermSecure\u00ae<\/sup> Screening Platform<\/i> Services to 176 communities across the province.<\/i>\n<\/p>\n

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX<\/a> #SkinCancer<\/a>—MedX Health Corp.<\/b> (“MedX” or the “Company”) (TSXV: MDX<\/b>), a global leader in teledermatology, and Central Health are pleased to announce the launch of MedX\u2019s DermSecure\u00ae<\/sup> skin screening services in Newfoundland and Labrador.\n<\/p>\n

<\/a><\/p>\n

\nThe paid pilot program, which will span 60 days, will see MedX implement its training program for nurses and supervisors to easily integrate the DermSecure\u00ae<\/sup> Screening Platform into the Central Health patient service offerings. Additionally, the Company will provide training for dermatologists who will be reading the scans and establishing the protocols in conjunction with mobile services already provided by Newfoundland\u2019s health care system to improve access to dermatological services in remote communities across the province. Upon the successful completion of the pilot, the MedX DermSecure\u00ae<\/sup> Screening Platform will be made available to Central Health\u2019s patients across Newfoundland and Labrador.\n<\/p>\n

\n“The paid pilot further verifies that our DermSecure platform meets all the necessary privacy and security requirements of a Canadian Provincial Government health care system,\u201d stated MedX Director of North American Sales, Paul Ziemer. \u201cThe challenges for physicians to effectively deliver care across this geography have been instrumental in Newfoundland and Labrador\u2019s prioritization and establishment of one of Canada\u2019s most robust telemedicine programs. The DermSecure platform and the images it provides for the doctors and dermatologists in the province will fit seamlessly into their telemedicine program and get the doctors and patients the information they need quickly and efficiently.\u201d\n<\/p>\n

\nCentral Health is the second largest health authority in Newfoundland and Labrador, serving approximately 93,000 people (18 per cent of the province\u2019s population) living in 176 communities. With a geographical area encompassing more than half the total land mass of the island, the Central Health region extends from Charlottetown in the east, Fogo Island in the north, Harbour Breton in the south, to Baie Verte in the west. Central Health provides a variety of primary, secondary, long-term care, community health, and other enhanced secondary services through:\n<\/p>\n